GE Healthcare offers a broad range of products and services that are improving productivity in healthcare and enhancing patient care by enabling healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions. Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. GE Healthcare Bio-Sciences AB, based in Uppsala, Sweden, has more than 40 years experience in developing, producing and marketing products for the separation and analysis of biomolecules and the company is a world leader in this area.


Biomarker discovery is an application area of particular interest and the company has a leading position in this market. The company intends to remain strong and grow in the biomarker area. In the Berzelii Centre, the company therefore has a firm interest in novel, commercially viable technologies related to biomarker discovery and detection. Ultimately, the company wishes to bring such technologies to market. GE Healthcare Bio-Sciences AB intends to contribute with protein analysis technology, know-how, and an industrial perspective on technology development.

Partner representative is MSc Daniel Ivansson, Senior research engineer at R&D. He has 10 years experience from the biotechnology industry, with a focus on technology scouting, research and product development within the protein analysis area.


Uppsala Berzelii Technology Centre for Neurodiagnostics | Email